A conference May 5-7, “The Biopolitics of Global Health After Covid-19,” will combine biopolitical and anthropological inquiry to spark a cross-disciplinary dialogue about (post-) pandemic discourses and practices of global health.
Cornell researchers have identified an antibiotic, rifampin, that is 99.9% effective against Salmonella Typhi, the bacterium that causes typhoid fever.
Researchers developed machine-learning models that can sift through cell-free RNA and identify key biomarkers for chronic fatigue syndrome, a debilitating disease that is difficult to confirm in patients because its symptoms can be easily confused with those of other illnesses.
Cornell researchers have developed an implant system that can treat Type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression.
Researchers have developed a rapid, cell-free method for building nanoparticle vaccines that mimic viruses at the molecular level, a technique that could pave the way for faster, more adaptable immunization strategies against deadly viruses like Nipah.